000			03115nam a22003377a 4500
001			CUHAS/MD/40001425/T/15
003			CUHAS/MD/40001425/T/15
005			20240305193850.0
008			210810b |||||||| |||| 00| 0 eng d
028			_bWurzburg Road 35, BMC Premises, Post Code: 33102:
028			_b P. O. Box 1464, Mwanza – Tanzania:
028			_bPhone: +255 28 298 3384:
028			_b Fax: +255 28 298 3386:
028			_bEmail: vc@bugando.ac.tz:
028			_bwww.bugando.ac.tz
035			_aCUHAS/MD/40001425/T/15
040			_bEnglish _cDDC
041			_aEnglish
041			_aKiswahili
100			_a Hosea, Veronica _921156 _dCUHAS/MD/40001425/T/15
245			_aFactors Associated with Utilization of Intermittent Preventive Treatment for Malaria During Pregnancy among Women attending at Sekou-Toure Hospital in Mwanza.
260			_aMwanza, Tanzania: _bCatholic University of Health and Allied Sciences [CUHAS – Bugando] : _c ©2020
300			_aix; 32 Pages
300			_aIncludes References
520			_aAbstract: Background: Malaria infection during pregnancy is a major public health problem in Africa, with substantial risks for the mother, her fetus and the neonate. WHO current recommends (IPTp-SP) to be given to all pregnant women starting at early second trimester with at least three dose during ANC visits. Official IPT3+ implementation programme of the new guidelines in Tanzania launched in 2014, with a current coverage of 56% for IPTp2 and 26% for IPTp3 (MIS/DHS 2018). Methodology: A descriptive cross-sectional study was conducted among women attending at Sekou Toure who met the inclusion criteria. Questionnaires and ANC was used to collect information, data was analyzed by using SPSS version 20 in computer. Results: Out of all enrolled participants (n=240), 80.5% had received optimal IPTp-SP doses (IPTp3+) a high coverage so far as it has met National target and more than half of participants received the dose under DOT. The main factors influenced IPTp-SP utilization and were statistically significance was Age, Marital status, Number of ANC visits, Gestation age at first visit, Distance to ANC clinic and knowledge on purpose of IPTp-SP with level of significance of 0.02, 0.00, 0.01, 0.01 and 0.02 respectively. Majority had no knowledge on at what gestation SP is given and the number of doses to be given throughout the pregnancy (65% and 66% respectively). Conclusion: The study showed high level of IPTp use that met the national target of 80% by 2013. The main factors which was associated with IPTp-SP utilization was ANC visit and the knowledge on purpose of IPTp-SP, also majority they didn’t know on when to start and how many dose of SP to given. Education on general knowledge on IPTp-SP during ANC tendency should be strengthened. Keywords: Intermitted preventive treatment, Malaria during pregnancy, IPTp-SP utilization.
600			_xCommunity Medicine
600			_xParasitology and Entolomology
700			_a Nyanza, Elias _919718
700			_aMaria Zinga
942			_2ddc _cCR
999			_c21118 _d21118